[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MC1552A1 - Procede de fabrication de compositions anti-herpes synergiques - Google Patents

Procede de fabrication de compositions anti-herpes synergiques

Info

Publication number
MC1552A1
MC1552A1 MC831663A MC1663A MC1552A1 MC 1552 A1 MC1552 A1 MC 1552A1 MC 831663 A MC831663 A MC 831663A MC 1663 A MC1663 A MC 1663A MC 1552 A1 MC1552 A1 MC 1552A1
Authority
MC
Monaco
Prior art keywords
compositions
manufacture
synergistic anti
anti herpes
herpes
Prior art date
Application number
MC831663A
Other languages
English (en)
French (fr)
Inventor
Kendall O Smith
Original Assignee
Ens Bio Logicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ens Bio Logicals Inc filed Critical Ens Bio Logicals Inc
Publication of MC1552A1 publication Critical patent/MC1552A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MC831663A 1982-11-04 1983-11-02 Procede de fabrication de compositions anti-herpes synergiques MC1552A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/439,121 US4462986A (en) 1982-11-04 1982-11-04 Synergistic anti-herpes compositions

Publications (1)

Publication Number Publication Date
MC1552A1 true MC1552A1 (fr) 1984-08-31

Family

ID=23743382

Family Applications (1)

Application Number Title Priority Date Filing Date
MC831663A MC1552A1 (fr) 1982-11-04 1983-11-02 Procede de fabrication de compositions anti-herpes synergiques

Country Status (10)

Country Link
US (1) US4462986A (de)
EP (1) EP0109234B1 (de)
JP (1) JPS59130223A (de)
AT (1) ATE26216T1 (de)
AU (1) AU557894B2 (de)
CA (1) CA1239093A (de)
DE (1) DE3370587D1 (de)
HK (1) HK77989A (de)
MC (1) MC1552A1 (de)
ZA (1) ZA838179B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4636383A (en) * 1984-08-29 1987-01-13 Schering Corporation Interferon-cyclaradine combination
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
US4857316A (en) * 1984-10-03 1989-08-15 Syntex (U.S.A.) Inc. Synergistic antiviral composition
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
JP2525104B2 (ja) * 1992-03-24 1996-08-14 日本碍子株式会社 樹脂含浸紙コンデンサコアおよびその製造方法
US5550114A (en) 1993-04-02 1996-08-27 Thomas Jefferson University Epidermal growth factor inhibitor
FI973784A (fi) * 1997-09-25 1999-03-26 Huhtamaeki Oy Ksylitolikaramelli, erityisesti kovakaramelli
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
WO2003030613A2 (en) * 2001-10-05 2003-04-17 Intermune, Inc. Methods of treating liver fibrosis and hepatitis c virus infection
EP1674104A1 (de) * 2004-12-24 2006-06-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Uridinderivaten als antivirale Agentien gegen Flavividae, insbesonders HCV
EP1991679A2 (de) * 2006-03-08 2008-11-19 Biomethodes Varianten des humanen interferon-gamma (ifngamma)
WO2013023362A1 (zh) * 2011-08-16 2013-02-21 深圳市卫武光明生物制品有限公司 静注巨细胞病毒人免疫球蛋白及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2134292A1 (en) * 1971-04-30 1972-12-08 Inst Nat Sante Rech Med Interferon compsns - contg halo desoxyuridines rifamycine or rifampycine
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
CS594082A2 (en) * 1981-08-11 1989-08-14 Wellcome Found Method of antiviral effective 2-amino-9-/(2-hydroxy-1-hydroxymethyl-ethoxy)methyl/purines production
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
EP0080032A3 (de) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmazeutische Zubereitung für die Behandlung von herpetischen Verletzungen
WO1983002723A1 (en) * 1982-02-12 1983-08-18 Smith, Kendall, O. Anti-viral compositions

Also Published As

Publication number Publication date
ZA838179B (en) 1985-03-27
DE3370587D1 (en) 1987-05-07
AU2068183A (en) 1984-05-10
EP0109234B1 (de) 1987-04-01
CA1239093A (en) 1988-07-12
ATE26216T1 (de) 1987-04-15
AU557894B2 (en) 1987-01-15
HK77989A (en) 1989-10-06
US4462986A (en) 1984-07-31
JPS59130223A (ja) 1984-07-26
EP0109234A1 (de) 1984-05-23

Similar Documents

Publication Publication Date Title
MC1552A1 (fr) Procede de fabrication de compositions anti-herpes synergiques
ES8700053A1 (es) Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales
SE8304408L (sv) Desoxiuridinderivat, forfaranden for deras framstellning och deras anvendning som lekemedel
DE3473272D1 (en) Guanine derivatives, compositions containing them, and their anti-viral use
GB8926595D0 (en) Pharmaceutical compositions for use in the treatment herpes simplex virus infections
AU9079491A (en) Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections
MY8800008A (en) Pharmaceutical composiitions for treating nail infections
IL65783A0 (en) Pharmaceutical composition for combating herpes simplex viruses types i and ii
CA2207503A1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
IT1168854B (it) Derivati di carbapenem dotati di attivita' antibiotica e procedimento per la loro preparazione
GB2108383B (en) Compound and composition for use against herpes virus
DE3590054D2 (en) Therapeutic agent for combating infections caused by herpes viruses
HU9503135D0 (en) Method of combating acyclovir-resistant herpes simplex viral infections
EP0260790A3 (de) Verwendung von Pinacidil zur Behandlung von Inkontinenz
CA2176392A1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
HK2688A (en) Topical preparation for treating herpes simplex virus
EP0400312A3 (de) Verfahren und Zusammensetzung zur Behandlung von Protozoen-Infektionen mit einem antibakteriellen Mittel
MX9102245A (es) Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes
CA2176376A1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
DE3274620D1 (en) Topical preparation for treating herpes simplex virus
EP0419354A3 (en) Use of a complex of inosine with a n,n-dialkylamino-alkanol or one of its salts with a pharmacologically acceptable acid for the treatment of certain helmintic infections

Legal Events

Date Code Title Description
YP Annual fee paid